| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BIX-01294 | CTRPv2 | pan-cancer | AAC | -0.14 | 6e-05 |
| mRNA | BRD-K09344309 | CTRPv2 | pan-cancer | AAC | 0.29 | 7e-05 |
| mRNA | PIK-93 | CTRPv2 | pan-cancer | AAC | -0.14 | 9e-05 |
| mRNA | TPCA-1 | GDSC1000 | pan-cancer | AAC | 0.11 | 9e-05 |
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0002 |
| mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0002 |
| mRNA | GDC-0941 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0005 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0007 |
| mRNA | PHA-793887 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.0008 |
| mRNA | N9-isopropylolomoucine | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0009 |